Ouro launches with $115M and a clinical-stage T-cell engager
14 hours ago · GSK-backed Ouro Medicines launches into T-cell engager space with $120M and a clinical-stage asset. By Darren Incorvaia Jan 10, 2025 6:00am. GSK bispecific antibodies B …
GSK-backed Ouro Launches With $115M to ‘Reset’ the Immune …
15 hours ago · Ouro is planning to leverage T cell engagers to deplete B cells and “reset” the immune system to treat immune-mediated diseases. ... GSK-backed Ouro Launches With …
Ouro Medicines Launches to Define the Future of Treatment for …
15 hours ago · News provided by Ouro Medicines Jan 10, 2025, 06:00 ET. Share this article. Share ... Ouro was founded by Monograph Capital in partnership with GSK. Ouro is also …
Immunology Startup Ouro Sets Out With $120M for Drugs That …
1 day ago · Ouro’s Series A round was co-led by TPG Life Sciences Innovations, NEA, and Norwest Venture Partners. Other disclosed investors in the financing include Monograph …
Ouro makes debut with $120m for autoimmune disease TCEs
12 hours ago · Ouro launches today with $120m in funding and a plan to develop bispecific antibody-based T-cell engagers for autoimmune ... Founded by Monograph Capital and GSK, …
Ouro Medicines Launches to Define the Future of Treatment for …
Company founded by Monograph Capital in partnership with GSK; Series A co-led by TPG, NEA, and Norwest. San Francisco, January 10, 2025-- Ouro Medicines, a biotechnology company …
Ouro Medicines Launches to Define the Future of Treatment
14 hours ago · Based in San Francisco and launched in 2025, Ouro was founded by Monograph Capital in partnership with GSK. Ouro is also backed by leading investors TPG, NEA, and …
Ouro Medicines Launches To Define The Future Of Treatment For …
1 day ago · Company founded by Monograph Capital in partnership with GSK; Series A co-led by TPG, NEA, and Norwest SAN FRANCISCO, Jan. 10, 2025 /PRNewswire/ -- Ouro Medicines, a …
Ouro, backed by GSK, joins hunt to bring bispecifics to …
1 day ago · Ouro, backed by GSK, joins hunt to bring bispecifics to autoimmune disease “Practice of medicine could fundamentally change with these types of therapies,” said CEO Jaideep …
TPG : Ouro Medicines Launches to Define the Future of Treatment …
11 hours ago · Ouro's approach is focused on leveraging T cell engagers in B cell mediated diseases to achieve immune resets that create durable remissions without ongoing …
- Some results have been removed